• Sonuç bulunamadı

Evaluation of Aflibercept Treatment Responses in Eyes with Bevacizumab/Ranibizumab-resistant Wet Age-related Macular Degeneration

N/A
N/A
Protected

Academic year: 2021

Share "Evaluation of Aflibercept Treatment Responses in Eyes with Bevacizumab/Ranibizumab-resistant Wet Age-related Macular Degeneration"

Copied!
5
0
0

Yükleniyor.... (view fulltext now)

Tam metin

Referanslar

Benzer Belgeler

Bununla ilgili olarak kuru tip YBMD tedavisinde ve Stargart maku- ler distrofisinde retina pigment epiteli kaynaklı insan embryojenik kök hücre tedavisini değerlendiren 2 ayrı Faz

Objectives: To evaluate the functional and morphological outcomes of vitrectomy in combination with intravitreal 5% C3F8 tamponade and subretinal injections of tissue

Objectives: To evaluate functional and anatomical responses to intravitreal aflibercept (IVA) treatment in newly diagnosed and untreated neovascular age-related macular

Geographic Atrophy Progression in Eyes with Age-Related Macular Degeneration: Role of Fundus Autofluorescence Patterns, Fellow Eye and Baseline Atrophy Area. Brar M, Kozak I, Cheng

In the OPERA study, consistent with our findings, the most common type of lesion observed in zone 2, superior zone 3, and inferior zone 3 color images from the patient and

Therefore, the aim of this prospective clinical trial was to characterize responses to anti-VEGF therapy with ranibizumab in eyes with active nvAMD, to analyze subgroups within the

Based on the aforementioned studies and our study, anti-VEGF therapy after cataract surgery halts and reverses active exudation and increases visual acuity in patients

Although our results did not show improvement in BCVA in parallel with the CFT reduction, intravitreal dexamethasone implant should still be considered as an effective and